32,280 results match your criteria Clostridium Difficile Colitis


AHRQ Evidence-based Practice Center Program: Applying the Knowledge to Practice to Data Cycle to Strengthen the Value of Patient Care.

J Hosp Med 2019 Feb 20;14:E1-E4. Epub 2019 Feb 20.

Agency for Healthcare Research and Quality, Center for Evidence and Practice Improvement, Rockville, Maryland.

For more than 20 years, the Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center (EPC) Program has been identifying and synthesizing evidence to inform evidence-based healthcare. Recognizing that many healthcare settings continue to face challenges in disseminating and implementing evidence into practice, AHRQ's EPC program has also embarked on initiatives to facilitate the translation of evidence into practice and to measure and monitor how practice changes impact health outcomes. The program has structured its efforts around the three phases of the Learning Healthcare System cycle: knowledge, practice, and data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/jhm.3157DOI Listing
February 2019

Implementation of infection prevention and control in acute care hospitals in Mainland China - a systematic review.

Antimicrob Resist Infect Control 2019 11;8:32. Epub 2019 Feb 11.

Infection Control Program and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland.

Background: Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) affect patients in acute-care hospitals worldwide. No systematic review has been published on adoption and implementation of the infection prevention and control (IPC) key components. The objective of this systematic review was to assess adoption and implementation of the three areas issued by the "National Health Commission of the People's Republic of China" in acute-care hospitals in Mainland China, and to compare the findings with the key and core components on effective IPC, issued by the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13756-019-0481-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371478PMC
February 2019

Clostridium difficile. A review on an emerging infection.

Clin Ter 2019 Jan-Feb;170(1):e41-e47

Section of Microbiology, Interdisciplinary Department of Medicine (DIM), School of Medicine, University of Bari " Aldo Moro", Bari - UOC Microbiology and Virology, Azienda Ospedaliera-Universitaria Policlinico of Bari, Bari.

Clostridium difficile causes antibiotic-associated diarrhoea and pseudomembranous colitis. The main virulence factors of C. difficile are the toxins A (TcdA) and B (TcdB). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7417/CT.2019.2106DOI Listing
February 2019

High 30-day readmission rates associated with Clostridiumdifficile infection.

Am J Infect Control 2019 Feb 15. Epub 2019 Feb 15.

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY.

Background: Clostridium difficile infection (CDI) is a leading cause of community-onset and healthcare-associated infection, with high recurrence rates, and associated high morbidity and mortality. We report national rates, leading causes, and predictors of hospital readmission for CDI.

Methods: Retrospective study of data from the 2013 Nationwide Readmissions Database of patients with a primary diagnosis of CDI and re-hospitalization within 30-days. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajic.2019.01.007DOI Listing
February 2019
1 Read

Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.

Clin Microbiol Infect 2019 Feb 13. Epub 2019 Feb 13.

Internal Medicine C, Sheba Medical Center, Israel; Sackler school of Medicine, Tel Aviv University, Tel Aviv, Israel.

Objectives: The role of asymptomatic carriers in CDI epidemiology is not fully understood. Our aim was to evaluate CD carriage prevalence on admission, associated risk factors and the risk to develop CDI.

Methods: A ten-week surveillance program for CD carriage of all medical patients admitted to the Sheba Medical Center was implemented, utilizing admission rectal swab PCR (Xpert C. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmi.2019.02.002DOI Listing
February 2019
1 Read

Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.

Infect Control Hosp Epidemiol 2019 Feb 15:1-5. Epub 2019 Feb 15.

Department of Internal Medicine,University of Iowa Carver College of Medicine,Iowa City, Iowa.

Objective: To characterize healthcare provider diagnostic testing practices for identifying Clostridioides (Clostridium) difficile infection (CDI) and asymptomatic carriage in children.

Design: Electronic survey.

Methods: An 11-question survey was sent by e-mail or facsimile to all pediatric infectious diseases (PID) members of the Infectious Diseases Society of America's Emerging Infections Network (EIN). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2018.347DOI Listing
February 2019
2 Reads

Increased Healthcare-Associated Infections in a Surgical Intensive Care Unit Related to Boarding Non-Surgical Patients.

Surg Infect (Larchmt) 2019 Feb 15. Epub 2019 Feb 15.

3 Department of Surgery, Division of Acute Care Surgery Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey.

Background: Hospital over-capacity often forces boarding patients outside of their designated intensive care unit (ICU). Anecdotal evidence suggested medical intensive care unit (MICU) patients boarding in the surgical intensive care unit (SICU) were responsible for increases in healthcare-associated infection (HAI) rates. We studied the effect of ICU boarding on rates of SICU HAIs. Read More

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/sur.2018.240
Publisher Site
http://dx.doi.org/10.1089/sur.2018.240DOI Listing
February 2019
3 Reads

Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan.

Clin J Gastroenterol 2019 Feb 14. Epub 2019 Feb 14.

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

We report a case of community-acquired fulminant colitis caused by Clostridium difficile in Japan. A 46-year-old woman was diagnosed with severe infectious enterocolitis and was admitted at another hospital. The stool culture was positive for toxigenic C. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12328-019-00949-zDOI Listing
February 2019
1 Read

Colitis in a Patient With Abdominal Distention, Pain, and Severe Constipation.

Fed Pract 2018 Jun;35(6):44-46

is a Staff Hospitalist at George E. Wahlen VAMC. is a Gastroenterology Fellow at the University of Utah School of Medicine, and Dr. Cowan is an Assistant Professor at the University of Utah Hospital Department of Internal Medicine, both in Salt Lake City.

This case reinforces the need to consider infectious disease as a possible cause of constipation for a patient on opioids. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368024PMC
June 2018
1 Read

Multidisciplinary evaluation of Clostridium butyricum clonality isolated from preterm neonates with necrotizing enterocolitis in South France between 2009 and 2017.

Sci Rep 2019 Feb 14;9(1):2077. Epub 2019 Feb 14.

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique - Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, Marseille, France.

The association between Clostridium species identification from stool samples in preterm neonates and the occurrence of necrotizing enterocolitis has been increasingly reported. To confirm the specific impact of Clostridium butyricum in this pathology, selective culture procedure was used for Clostridia isolation. Whole-genome analysis was employed to investigate genomic relationships between isolates. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41598-019-38773-7
Publisher Site
http://dx.doi.org/10.1038/s41598-019-38773-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376027PMC
February 2019
2 Reads

Prevalence and antimicrobial susceptibility pattern of toxigenic Clostridium difficilestrains isolated in Iran

Turk J Med Sci 2019 Feb 11;49(1):384-391. Epub 2019 Feb 11.

Background/aim: Clostridium difficile is a frequent cause of nosocomial infections and has become a major public health concern in developed nations. In the present study, the prevalence and antimicrobial susceptibility pattern of toxigenic C. difficile strains isolated in Iran were investigated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3906/sag-1808-11DOI Listing
February 2019

Investigational drug therapies currently in early stage clinical development for the treatment of clostridioides (clostridium) difficile infection.

Expert Opin Investig Drugs 2019 Feb 12. Epub 2019 Feb 12.

d R M Alden Research Laboratory , Santa Monica , CA 90404 , USA.

Introduction: Clostridioides (Clostridium) difficile Infection (CDI) is an urgent global threat causing ~500,000 infections annually in the United States of America (USA) and is associated with a 36% 30-day attributable mortality rate. Despite the availability of three therapeutic agents, CDI recurrence occurs in 20-40% of patients, with a 30-40% second recurrence rate in these patients. Consequently, there is a need for novel agents for treating CDI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2019.1581763DOI Listing
February 2019

[Guideline for fecal bacteriotherapy to treat recurrent Clostridium difficile colitis].

Klin Mikrobiol Infekc Lek 2018 Jun;24(2):57-64

Department of Inectious Diseases, 3rd Medical faculty, Charles University, Prague, Hospital na Bulovce, Czech Republic, e-mail:

We present a case of a 17-year-old female with anti-NMDAR encephalitis probably associated with vaccination against yellow fever. Her symptoms occurred 27 days after vaccination against yellow fever. Anti-NMDAR encephalitis manifested as acute psychosis, memory loss and catatonia following fever with complex partial epileptic seizures. Read More

View Article

Download full-text PDF

Source
June 2018
1 Read

Analysis of risk factors and outcomes of Clostridium difficile infection.

Folia Med Cracov 2018 ;58(4):105-116

Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, Kraków; University Hospital in Kraków, Poland.

Introduction: Clostridium difficile (C. difficile) is a Gram-positive, anaerobic rod-shaped bacteria, widely spread in the human environment. In the last decade, the frequency and severity of Clostridium difficile infection (CDI) have been increasing, making this particular disease one of the most significant nosocomial infections. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

Risk factors for contagious gastroenteritis in adult patients with diarrhoea in the emergency department - a prospective observational multicentre study.

BMC Infect Dis 2019 Feb 11;19(1):133. Epub 2019 Feb 11.

Focused Research Unit in Emergency Medicine, Hospital of Southern Denmark, Kresten Philipsens Vej 15, DK-6200, Aabenraa, Denmark.

Background: Infectious gastroenteritis is common in the emergency department (ED). Patients infected with either Norovirus or toxigenic Clostridium difficile require special isolation procedures. The aims were to describe the aetiology of infectious gastroenteritis in the ED, evaluate whether current isolation procedures, based on clinical judgement are sufficient, and to identify information that might be used to identify patients requiring isolation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-019-3754-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371479PMC
February 2019
1 Read

Non-Carbapenem Antibiotics to Treat Severe Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Infections in Intensive Care Unit Patients.

Int J Antimicrob Agents 2019 Feb 8. Epub 2019 Feb 8.

Service de Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris.

Purpose: To evaluate the use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit (ICU) patients.

Methods: This retrospective observational study conducted in 2 ICUs compared outcomes of patients with extended-spectrum β-lactamase-producing Enterobacteriaceae infections administered a carbapenem or a non-carbapenem antibiotic as their definitive treatment. The primary outcome was treatment failure within 30 days, a composite endpoint of extended-spectrum β-lactamase-producing Enterobacteriaceae-infection recurrence and day-30 mortality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2019.02.001DOI Listing
February 2019
1 Read

Thirty Years of Lactobacillus rhamnosus GG: A Review.

Authors:
Lucio Capurso

J Clin Gastroenterol 2019 Mar;53 Suppl 1:S1-S41

Department of Gastroenterology, San Filippo Neri Hospital, Rome, Italy.

Lactobacillus rhamnosus GG (LGG) was the first strain belonging to the genus Lactobacillus to be patented in 1989 thanks to its ability to survive and to proliferate at gastric acid pH and in medium containing bile, and to adhere to enterocytes. Furthermore LGG is able to produces both a biofilm that can mechanically protect the mucosa, and different soluble factors beneficial to the gut by enhancing intestinal crypt survival, diminishing apoptosis of the intestinal epithelium, and preserving cytoskeletal integrity. Moreover LGG thanks to its lectin-like protein 1 and 2 inhibits some pathogens such as Salmonella species. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000001170DOI Listing
March 2019
1 Read

Neutropenic Enterocolitis in Critically Ill Patients: Spectrum of the Disease and Risk of Invasive Fungal Disease.

Crit Care Med 2019 Feb 7. Epub 2019 Feb 7.

Medical Intensive Care Unit, Hospital Saint Louis, Assistance Publique - Hôpitaux de Paris, France.

Objectives: Neutropenic enterocolitis occurs in about 5.3% of patients hospitalized for hematologic malignancies receiving chemotherapy. Data from critically ill patients with neutropenic enterocolitis are scarce. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003687DOI Listing
February 2019
1 Read

a new species within the genus .

New Microbes New Infect 2019 Mar 31;28:6-10. Epub 2018 Dec 31.

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEΦI), Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Using the strategy of taxonogenomics, we described sp. nov. strain Marseille-P3100, a Gram-variable, nonmotile, spore-forming anaerobic bacillus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmni.2018.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357548PMC

The impact of corticosteroid use on inpatients with inflammatory bowel disease and positive polymerase chain reaction for Clostridium difficile.

Intest Res 2019 Feb 12. Epub 2019 Feb 12.

Division of Gastroenterology and Hepatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.

Background/aims: : Optimal management of inflammatory bowel disease (IBD) with concomitant Clostridium difficile infection (CDI) is controversial, especially when CDI diagnosis is made by polymerase chain reaction (PCR) testing, which may reflect colonization without infection.

Methods: We performed a multicenter review of all inpatients with IBD and PCR diagnosed CDI. Outcomes included length of stay, 30- and 90-day readmission, colectomy during admission and within 3 months, intensive care unit (ICU) admission, CDI relapse and death for patients who received CS after CDI diagnosis versus those that did not. Read More

View Article

Download full-text PDF

Source
http://www.irjournal.org/journal/view.php?doi=10.5217/ir.201
Publisher Site
http://dx.doi.org/10.5217/ir.2018.00101DOI Listing
February 2019
2 Reads

Multidisciplinary Approach and Clostridium difficile Infection in Adult Surgical Patients.

J Am Coll Surg 2019 Feb 7. Epub 2019 Feb 7.

Department of Surgery, Duke University Medical Center, Durham, NC.

Background: In 2017, our hospital was identified as a "High Outlier" for postoperative Clostridium difficile infections (CDI) in the American College of Surgeons NSQIP semi-annual report. The Department of Surgery initiated an CDI Task Force with representation from Surgery, Infectious Disease, Pharmacy, and Performance Services to analyze available data, identify opportunities for improvement, and implement strategies to reduce CDI.

Study Design: Strategies to reduce CDI were reviewed from the literature and multi-disciplinary strategies were initiated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2018.12.045DOI Listing
February 2019
2 Reads

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematological malignancies carrying multidrug-resistance bacteria.

Haematologica 2019 Feb 7. Epub 2019 Feb 7.

Department of Hematology, Saint Antoine Hospital, Paris, France.

Fecal microbiota transplantation is an effective treatment in recurrent Clostridium difficile infection. Promising results to eradicate multidrug-resistant bacteria have also been reported with this procedure, but there are safety concerns in immunocompromised patients. We report results in 10 adult patients colonized with multidrug-resistant bacteria, undergoing fecal microbiota transplantation before (n=4) or after (n=6) allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.198549DOI Listing
February 2019
3 Reads

Hospital-associated Clostridium difficile infection and reservoirs within the hospital environment.

Am J Infect Control 2019 Feb 2. Epub 2019 Feb 2.

Department of Infection Control, University of Pittsburgh Medical Center, Pittsburgh, PA; University of Pittsburgh School of Public Health, Pittsburgh, PA. Electronic address:

Background: Clostridium difficile infection (CDI) is a leading cause of hospital-associated infections. Antibiotic stewardship, environmental disinfection, and reduction of transmission via health care workers are the major modes of CDI prevention within hospitals.

Methods: The aim of this study was to evaluate the role of the environment in the spread of CDI within hospital rooms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajic.2018.12.013DOI Listing
February 2019

Treatment of Recurrent Clostridium difficile Infection-Reply.

JAMA 2019 02;321(5):513

Department of Internal Medicine, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.19004DOI Listing
February 2019

Treatment of Recurrent Clostridium difficile Infection.

JAMA 2019 02;321(5):512-513

Hines VA Hospital, Hines, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.18993DOI Listing
February 2019

Vancomycin Enema in the Treatment of Clostridium difficile Infection.

Surg Infect (Larchmt) 2019 Feb 4. Epub 2019 Feb 4.

Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan.

Background: Current guidelines for the treatment of Clostridium difficile infections (CDIs) recommend vancomycin enemas for patients with adynamic ileus. There is significant variability in guideline recommendations for vancomycin dose and enema volume and whether a retention enema should be used. The most recent (2017) guidelines from the Infectious Diseases Society of America/Society for Healthcare Epidemiology of America recommend rectal instillation of 500 mg of vancomycin in 100 mL of physiologic saline every 6 hours as a retention enema. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/sur.2018.238DOI Listing
February 2019
1 Read

Prolonged non-operative management of clostridium difficile colitis is associated with increased mortality, complications, and cost.

Am J Surg 2019 Jan 24. Epub 2019 Jan 24.

Department of Surgery, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA; Center for Advanced Surgical Technology, Nebraska Medical Center, 985126 Nebraska Medical Center, Omaha, NE, 68198-6245, USA. Electronic address:

Background: We aim to investigate the effects of delaying surgery on outcomes and cost in patients admitted with severe clostridium difficile infection (CDI).

Methods: The Vizient database was queried for patients with CDI who underwent open total abdominal colectomy (TAC). Patients operated on the day of admission were excluded. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2019.01.017DOI Listing
January 2019

The emergence of metronidazole and vancomycin reduced-susceptibility in Clostridium difficile isolates in Iran.

J Glob Antimicrob Resist 2019 Jan 28. Epub 2019 Jan 28.

Dept of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address:

Objectives: Clostridium difficile is the main causative agent of antibiotic-associated diarrhoea (AAD) and pseudomembranous colitis (PMC). The accumulation of antimicrobial resistance in C. difficile strains can drive Clostridium difficile infection (CDI) epidemiology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgar.2019.01.027DOI Listing
January 2019
1 Read

Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.

Methods 2019 Jan 28. Epub 2019 Jan 28.

Infections and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. Electronic address:

Serological assays detecting antibodies in serum or plasma samples are useful and versatile instruments to investigate an individual's infection and vaccination history, e.g. for clinical diagnosis, personal risk evaluation, and seroepidemiological studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2019.01.013DOI Listing
January 2019
1 Read

Clostridium difficile in inflammatory bowel disease.

Ter Arkh 2018 Nov;90(11):32-36

A.S. Loginov Moscow Сlinical Scientific Сenter, Moscow, Russia.

Aim: To study epidemiology and risk factors for Clostridium infection (CDI) associated with Clostridium difficile in patients with inflammatory bowel disease (IBD).

Materials And Methods: 1179 medical records were analyzed in a retrospective study of patients with IBD, of which 764 patients met the inclusion criteria. Patients were divided into 2 groups based on the presence of a preliminary diagnosis of CDI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/terarkh2018901132-36DOI Listing
November 2018
7 Reads

The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.

mSphere 2019 01 30;4(1). Epub 2019 Jan 30.

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA

() , a Gram-positive, anaerobic bacterium, is the leading single cause of nosocomial infections in the United States. A major risk factor for infection (CDI) is prior exposure to antibiotics, as they increase susceptibility to CDI by altering the membership of the microbial community enabling colonization. The importance of the gut microbiota in providing protection from CDI is underscored by the reported 80 to 90% success rate of fecal microbial transplants in treating recurrent infections. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/mSphereDirect.00698-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354811PMC
January 2019
1 Read

Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication.

FASEB J 2019 Jan 30:fj201802453R. Epub 2019 Jan 30.

Institute of Pharmacology and Toxicology, University of Ulm Medical Center, Ulm, Germany.

The antibiotic bacitracin (Bac) inhibits cell wall synthesis of gram-positive bacteria. Here, we discovered a totally different activity of Bac: the neutralization of bacterial exotoxins. Bac prevented intoxication of mammalian cells with the binary enterotoxins Clostridium botulinum C2, C. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201802453RDOI Listing
January 2019
1 Read

Updated guidelines for diagnosing and managing Clostridium difficile.

JAAPA 2019 Feb;32(2):48-50

Margaret Rancich is a student in the PA program at Butler University in Indianapolis, Ind. Christopher Roman is an assistant professor in the PA program at Butler University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

The updated Infectious Disease Society of America guidelines for managing Clostridium difficile infections remove metronidazole as first-line therapy and add fecal microbiota transplants to the treatment options. This article reviews the new guidelines and strategies for diagnosis and infection control. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JAA.0000552734.33929.01DOI Listing
February 2019

Clostridium difficile Colitis Prevention and Treatment.

Adv Exp Med Biol 2019 Jan 29. Epub 2019 Jan 29.

KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

Clostridium difficile (C. diff) is the most common causative agent of antibiotic-associated diarrhea and colitis. This spore-forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and in hospital settings, whose severity can vary widely from an asymptomatic infection to a lethal disease. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/5584_2018_322
Publisher Site
http://dx.doi.org/10.1007/5584_2018_322DOI Listing
January 2019
3 Reads

Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review.

North Clin Istanb 2018 Sep;5(3):256-260

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA.

Clostridium difficile infection (CDI) is a major cause of morbidity and mortality in patients with inflammatory bowel disease (IBD), especially in ulcerative colitis (UC). The incidence and severity of CDI in IBD has shown an increasing trend in the last two decades. Patients with IBD are predisposed to CDI secondary to the recurrent use of antibiotics, corticosteroids, and immunosuppressants and secondary to dysbiosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14744/nci.2017.79446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323562PMC
September 2018
1 Read

Colorectal Surgical Site Infection Prevention Kits Prior to Elective Colectomy Improve Outcomes.

Ann Surg 2019 Jan 24. Epub 2019 Jan 24.

Colorectal Center, Massachusetts General Hospital, Boston MA.

MINI: We began a quality improvement project distributing free Surgical Site Infection Prevention Kits (SSIPK) to all patients undergoing elective colectomy. Patients who received the kit, compared to propensity matched controls who did not receive the kit, had fewer postoperative surgical site infections, lower rates of postoperative ileus, shorter hospital lengths of stay, and fewer readmissions.

Introduction: Patient compliance with preoperative mechanical and antibiotic bowel preparation, skin washes, carbohydrate loading, and avoidance of fasting are key components of successful colorectal ERAS and surgical site infection (SSI)-reduction programs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000003194DOI Listing
January 2019
1 Read

Does an antimicrobial stewardship program's interventions reduce the rate of and protect against Clostridium difficile infection?

J Glob Antimicrob Resist 2019 Jan 22. Epub 2019 Jan 22.

Department of Pharmacy, Singapore General Hospital, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore; Emerging Infectious Disease Program, Duke-National University of Singapore Medical School, Singapore. Electronic address:

Background: To minimize Clostridium difficile infections (CDI) incidence which can be life-threatening, Antimicrobial Stewardship Programs (ASP) have often been recommended as a viable solution. Our study aims to evaluate whether ASP interventions have contributed to reducing CDI rates.

Methods: A retrospective review of ASP interventions issued from January 2013 to April 2014 was performed using data from the ASP database of Singapore General Hospital (SGH), a 1600-bed tertiary-care hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgar.2019.01.018DOI Listing
January 2019
1 Read

Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center.

Int J Infect Dis 2019 Jan 22;80:105-110. Epub 2019 Jan 22.

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Department of Internal Medicine, Università Cattolica del Sacro Cuore, Roma, Italy.

Background: Clostridium Difficile Infections (CDIs) have been increasing both in incidence and in severity, representing a big public health concern.

Aim: The aim of this study was to evaluate the impact of a recently implemented Critical Pathway (CP) focused on patients with CDI in an Italian Teaching Hospital.

Methods: The CP implementation consisted of intervention aimed to faster diagnosis and appropriateness in admission and discharge point of care; activation of a multidisciplinary team; staff training; information to patients and caregivers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2019.01.025DOI Listing
January 2019
1 Read

Plazomicin (Zemdri) - a new aminoglycoside antibiotic.

Authors:

Med Lett Drugs Ther 2018 Nov;60(1559):180-182

View Article

Download full-text PDF

Source
November 2018
1 Read

Molecular epidemiology of infection in Iranian hospitals.

Antimicrob Resist Infect Control 2019 14;8:12. Epub 2019 Jan 14.

8Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada.

Background: infection (CDI) is known as one of the most important causes of nosocomial infections. The main objective of this study was to evaluate the presence of in the stool of hospitalized patients with diarrhea as well as in their environments.

Methods: isolates were characterized according to the presence of toxin genes and antibiotic resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13756-018-0454-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332892PMC
January 2019

Diagnosis of infection by toxigenic culture and PCR assay.

Iran J Microbiol 2018 Oct;10(5):287-293

Infectious Diseases & Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran.

Background And Objectives: is responsible for 15-25% of nosocomial antibiotic associated diarrhea (AAD) cases and all cases of pseudomembranous colitis. has two major virulence factors, toxin A (enterotoxin) and toxin B (cytotoxin). The aim of this study was to determine the frequency of strains in patients with diarrhea in Babol' hospitals with toxigenic culture and PCR assay. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339995PMC
October 2018
1 Read

Outcomes of Community and Healthcare-onset Clostridium difficile Infections.

Clin Infect Dis 2018 Aug 23. Epub 2018 Aug 23.

William S. Middleton Memorial Veterans Affairs Hospital, Madison.

Background: Community-onset Clostridium difficile infections (CDI) are increasingly common, but there is little data on outcomes. The purpose of this study is to describe the epidemiology and outcomes of CDI in the Veterans Health Administration (VHA) system and compare these variables between hospital-onset (HCF) and community-onset (CO) cases.

Methods: We conducted a retrospective cohort study that included all patients with a positive test for C. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy715DOI Listing
August 2018
1 Read

Gut microbiota density influences host physiology and is shaped by host and microbial factors.

Elife 2019 Jan 22;8. Epub 2019 Jan 22.

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, United States.

To identify factors that regulate gut microbiota density and the impact of varied microbiota density on health, we assayed this fundamental ecosystem property in fecal samples across mammals, human disease, and therapeutic interventions. Physiologic features of the host (carrying capacity) and the fitness of the gut microbiota shape microbiota density. Therapeutic manipulation of microbiota density in mice altered host metabolic and immune homeostasis. Read More

View Article

Download full-text PDF

Source
https://elifesciences.org/articles/40553
Publisher Site
http://dx.doi.org/10.7554/eLife.40553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342524PMC
January 2019
3 Reads
8.519 Impact Factor

Pediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admission.

Pediatr Blood Cancer 2019 Jan 21:e27604. Epub 2019 Jan 21.

Department of Pathology, Sidra Medicine and Weill Cornell Medical College in Qatar, Doha, Qatar.

Clostridium difficile is the leading cause of healthcare-associated infections worldwide. The diagnosis of C. difficile infection (CDI) in pediatric oncology patients is complex as diarrhea is common, and there is a high rate of colonization in infants and young children. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27604
Publisher Site
http://dx.doi.org/10.1002/pbc.27604DOI Listing
January 2019
5 Reads

Prevalence of Clostridium difficile Infections Among Kenyan Children with Diarrhea.

Int J Infect Dis 2019 Jan 17. Epub 2019 Jan 17.

University of Texas Health Science Center, School of Public Health, Department of Epidemiology, Human Genetics, and Environmental Sciences, Center for Infectious Diseases, Houston, Texas, USA; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Microbiology and Infectious Diseases Program, Houston, Texas, USA. Electronic address:

Background: Diarrhea causes significant morbidity and mortality among children worldwide. Regions most affected by diarrhea are the sub-Saharan African and Southeast Asia, where antibiotics are in common use and can make children more vulnerable to Clostridium difficile and pathogens which are not affected by these drugs. Indeed, Clostridium difficile is a major diarrhea-associated pathogen and poses a significant threat to vulnerable and immunocompromised populations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2019.01.024DOI Listing
January 2019
2 Reads

bacteremia in an immunocompetent patient.

IDCases 2019 2;15:e00481. Epub 2019 Jan 2.

Department of Infectious Disease, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia 25701, USA.

Of the 200 spp. known to exist, approximately 30 have been associated with human disease. Commonly found in soil, marine sediment and mammalian intestinal tracts, these gram-positive bacilli are known to cause infections ranging from cellulitis to septicemia. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22142509183020
Publisher Site
http://dx.doi.org/10.1016/j.idcr.2018.e00481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327907PMC
January 2019
5 Reads

A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in rats.

Sci Rep 2019 Jan 17;9(1):158. Epub 2019 Jan 17.

School of Chemical and Physical Sciences, Flinders University, Bedford Park, SA, Australia.

Drug resistant bacteria are winning the fight over antibiotics with some bacteria not responding to any antibiotics, threatening modern medicine as we know it. The development of new, effective and safe antibiotics is critical for addressing this issue. Ramizol, a first-in-class styrylbenzene based antibiotic, is an investigational drug indicated for Clostridium difficile infections (CDI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-36690-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336794PMC
January 2019
1 Read

Fulminant pseudomembranous enterocolitis caused by : an autopsy case report.

Acute Med Surg 2019 Jan 24;6(1):78-82. Epub 2018 Oct 24.

Department of Traumatology and Critical Care Medicine National Defense Medical College Saitama Japan.

Case: We describe a rare case of antibiotic-associated fulminant pseudomembranous enterocolitis caused by . A 79-year-old man with a history of antibiotic therapy was admitted to our emergency department, complaining of consciousness disturbance. Initially, we suspected septic shock and diabetic ketoacidosis caused by intestinal infection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ams2.370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328918PMC
January 2019
2 Reads

A specific synbiotic-containing amino acid-based formula in dietary management of cow's milk allergy: a randomized controlled trial.

Clin Transl Allergy 2019 15;9. Epub 2019 Jan 15.

10Great North Children's Hospital, Newcastle upon Tyne, UK.

Background: Here we report follow-up data from a double-blind, randomized, controlled multicenter trial, which investigated fecal microbiota changes with a new amino acid-based formula (AAF) including synbiotics in infants with non-immunoglobulin E (IgE)-mediated cow's milk allergy (CMA).

Methods: Subjects were randomized to receive test product (AAF including fructo-oligosaccharides and M-16V) or control product (AAF) for 8 weeks, after which infants could continue study product until 26 weeks. Fecal percentages of bifidobacteria and / group () were assessed at 0, 8, 12, and 26 weeks. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13601-019-0241-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332540PMC
January 2019
16 Reads